Tibet Duo Rui Pharmaceutical (301075.SZ) plans to establish Tibet Ruishengxiang Pharmaceutical Co., Ltd.

16:06 07/11/2025

Duo Rui Pharmaceuticals (301075.SZ) announced that, according to the company's operating and strategic development needs, in order to optimize the company's overall...

Tibet Duo Rui Pharmaceutical (301075.SZ) announced that, for the optimization of the company's headquarters management functions and strategic development needs, the company has established a wholly-owned subsidiary, Tibet Ruishengxiang Pharmaceutical Co., Ltd., with a registered capital of 2 million yuan.

Jiangsu Hengrui Pharmaceuticals (01276) transferred the repurchased 13.5111 million A shares to the employee stock ownership plan.

EDIANYUN (02416) spent 528,800 Hong Kong dollars on repurchasing 260,000 shares on November 7th.

Bohai Leasing (000415.SZ) plans to sell 818 million shares of equity in Wanjiang Jinzu to recover investment funds.

Jiangsu Hengrui Pharmaceuticals (01276) transferred the repurchased 13.5111 million A shares to the employee stock ownership plan.

EDIANYUN (02416) spent 528,800 Hong Kong dollars on repurchasing 260,000 shares on November 7th.

Bohai Leasing (000415.SZ) plans to sell 818 million shares of equity in Wanjiang Jinzu to recover investment funds.